Clinical Report: Accessibility and Decision-Support Quality of BBD Content on WeChat

Overview

The supplied article context describes a nationwide cross-sectional study examining accessibility and decision-support quality of benign breast disease (BBD) content on Chinese hospital WeChat accounts. The provided material does not include the study’s methods, sample size, numerical results, or conclusions, so findings about account performance cannot be reported.

Background

BBD accounts for an estimated 55% to 90% of breast lesions, and subsequent breast cancer risk varies with epithelial proliferation and atypia. Unlike malignancy, BBD does not have uniform evidence-based management protocols, and care may involve surveillance, biopsy, surgery, or follow-up. The source describes shared decision-making as important when choices depend on individual risk and patient preferences, while noting that decision aids can be difficult to incorporate into routine care, particularly in resource-constrained settings. Telemedicine is identified as a means of supporting interactive decision-making.

Data Highlights

The supplied article excerpt contains no study-specific numerical results, sample characteristics, or measures of accessibility or decision-support quality. It reports background estimates that BBD comprises 55% to 90% of breast lesions.

Key Findings

• The article is identified as a nationwide cross-sectional study of BBD content on Chinese hospital WeChat accounts.
• The supplied excerpt does not report the study’s sample size, assessment methods, or results; no account-level quality findings can therefore be summarized.
• BBD represents an estimated 55% to 90% of breast lesions, according to the cited background literature.
• Breast cancer risk after BBD varies according to epithelial proliferation and atypia.
• The source describes BBD management as potentially involving surveillance, biopsy, surgery, or follow-up, with individualized approaches in the absence of uniform evidence-based protocols.
• The source cites professional guidance recommending shared decision-making for relevant breast lesion management; it also notes that integrating patient decision aids into routine clinical workflows remains a challenge.

Clinical Implications

The supplied material supports the relevance of accessible, decision-supportive BBD information, but it does not provide results that establish the quality or adequacy of WeChat content. Clinical decisions should be framed around the individual lesion, risk, and patient preferences, consistent with the shared decision-making context described in the source.

Conclusion

The excerpt establishes the clinical rationale for evaluating BBD information on hospital WeChat accounts but does not provide the study’s findings. Conclusions about accessibility or decision-support quality require the full study results.

Related Resources & Content

1. Codd R, Gateley CA, Surgery (Oxford), 2007 -- Management of benign disease of the breast
2. Rao R et al, Annals of Surgical Oncology, 2018 -- Select choices in benign breast disease: an initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely Campaign
3. Rubio IT et al, European Journal of Surgical Oncology, 2024 -- European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions)
4. Bussey LG, Sillence E, DIGITAL HEALTH, 2019 -- The role of internet resources in health decision-making: a qualitative study
5. BMC Psychiatry (Springer) — Effects of a WeChat-based self-help psychological and rehabilitation intervention on disease acceptance, emotional states, death attitudes, resilience, and mindfulness in breast cancer women
6. Frontiers in Oncology — Acceptance of Telemedicine for Breast Cancer Follow-Up Among Patients: A Cross-Sectional Analysis from Eastern China
7. DIGITAL HEALTH — A sentiment analysis and topic modeling of weibo discourse on public perceptions of breast cancer
8. The ASCO Post — ASCO Quality Care 2017: Study Examines Cancer Center Websites’ Information on Breast Cancer Treatment, Outcomes Key Points
9. ACR Appropriateness Criteria: Palpable Breast Masses
10. American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions
11. 乳腺叶状肿瘤诊疗临床实践指南（2025版） - 中国学术期刊网络出版总库